Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
IONIS PHARMACEUTICALS INC (IONS)
Sector: Healthcare; Industry: Biotechnology

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company is also developing severe and rare disease products, such as WAYLIVRA, a treatment for familial chylomicronemia syndrome; WAYLIVRA, a treatment for familial partial lipodystrophy; AKCEA-TTR-LRx for transthyretin amyloidosis and IONIS-GHR-LRx for acromegaly; and IONIS-TMPRSS6-LRx for beta-thalassemia and iron toxicity, IONIS-PKKRx/IONIS-PKK-LRx for hereditary angioedema, and IONIS-ENAC-2.5Rx for cystic fibrosis. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-07-15 KLEIN JOSEPH III Director Sell 4,334 $35.30 $152,989 Yes
2021-06-23 BERTHELSEN SPENCER R Director Sell 15,000 $37.74 $566,100 Yes
2021-06-15 MUTO FREDERICK T Director Sell 15,000 $36.63 $549,500 Yes
2021-03-01 Monia Brett P Chief Executive Officer Sell 236 $54.27 $12,809 No
2021-01-26 CROOKE STANLEY T Exec Chairman of the Board Sell 28,333 $63.74 $1,805,812 No
2021-01-25 O'NEIL PATRICK R. EVP & General Counsel Sell 5,324 $63.50 $338,074 No
2021-01-22 CROOKE STANLEY T Exec Chairman of the Board Sell 75,000 $61.45 $4,609,117 No
2021-01-13 Geary Richard S EVP, Chief Development Offc Sell 141 $59.50 $8,390 No
2021-01-05 Swayze Eric EVP, Research Sell 195 $55.99 $10,918 Yes
2020-12-23 PARSHALL B LYNNE Director Sell 10,000 $60.00 $600,000 No
2020-12-17 CROOKE STANLEY T Exec Chairman of the Board Sell 40,407 $49.80 $2,012,278 No
2020-12-07 CROOKE STANLEY T Exec Chairman of the Board Sell 11,000 $51.67 $568,350 No
2020-12-04 Monia Brett P Chief Executive Officer Sell 23,840 $51.04 $1,216,794 Yes
2020-12-04 BENNETT C FRANK Chief Scientific Officer Sell 7,947 $51.04 $405,615 Yes
2020-12-02 BENNETT C FRANK Chief Scientific Officer Sell 7,053 $51.32 $361,960 Yes
2020-12-02 Monia Brett P Chief Executive Officer Sell 21,160 $51.32 $1,085,931 Yes
2020-11-25 HOUGEN ELIZABETH L EVP, Finance & CFO Sell 21,680 $50.05 $1,085,084 Yes
2020-11-25 CROOKE STANLEY T Exec Chairman of the Board Sell 12,990 $50.05 $650,150 Yes
2020-11-25 Geary Richard S EVP, Development Sell 11,920 $50.05 $596,596 Yes
2020-11-25 PARSHALL B LYNNE Director Sell 3,590 $50.05 $179,680 Yes
2020-11-24 CROOKE STANLEY T Exec Chairman of the Board Sell 14,690 $50.23 $737,926 Yes
2020-11-24 HOUGEN ELIZABETH L EVP, Finance & CFO Sell 23,320 $50.24 $1,171,676 Yes
2020-11-24 Geary Richard S EVP, Development Sell 13,080 $50.24 $657,152 Yes
2020-11-24 PARSHALL B LYNNE Director Sell 3,910 $50.25 $196,466 Yes
2020-11-03 BENNETT C FRANK Chief Scientific Officer Sell 15,000 $46.77 $701,600 Yes
2020-10-20 KLEIN JOSEPH III Director Sell 2,889 $46.86 $135,386 No
2020-09-22 CROOKE STANLEY T Exec Chairman of the Board Sell 52,000 $50.40 $2,620,820 No
2020-09-01 Monia Brett P Chief Executive Officer Sell 314 $53.70 $16,862 No
2020-06-25 Castleman Breaux Director Sell 10,000 $60.00 $600,000 Yes
2020-06-25 BENNETT C FRANK EVP, Chief Scientific Officer Sell 15,000 $59.77 $896,505 Yes

Insider Smart

MGM Resorts International (MGM) - If we were to pick one of the easy trade from the crash, it has to be MGM, checkout the impressive insider buying after crash. Do you really need more confidence to pull the trigger? That's the mental edge you need to work against fear.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.